The Long-Term Survival of a Patient With Stage IV Renal Cell Carcinoma Following an Integrative Treatment Approach Including the Intravenous α-Lipoic Acid/Low-Dose Naltrexone Protocol
Open Access
- 19 December 2017
- journal article
- case report
- Published by SAGE Publications in Integrative Cancer Therapies
- Vol. 17 (3) , 986-993
Abstract
In this case report, we describe the treatment of a 64-year-old male patient diagnosed with metastatic renal cell carcinoma (RCC) in June of 2008. In spite of a left nephrectomy and the standard oncological protocols, the patient developed a solitary left lung metastasis that continued to grow. He was informed that given his diagnosis and poor response to conventional therapy, any further treatment would, at best, be palliative. The patient arrived at the Integrative Medical Center of New Mexico in August of 2010. He was in very poor health, weak, and cachectic. An integrative program—developed by one of the authors using intravenous (IV) α-lipoic acid, IV vitamin C, low-dose naltrexone, and hydroxycitrate, and a healthy life style program—was initiated. From August 2010 to August 2015, the patient’s RCC with left lung metastasis was followed closely using computed tomography and positron emission tomography/computed tomography imaging. His most recent positron emission tomography scan demonstrated no residual increased glucose uptake in his left lung. After only a few treatments of IV α-lipoic acid and IV vitamin C, his symptoms began to improve, and the patient regained his baseline weight. His energy and outlook improved, and he returned to work. The patient had stable disease with disappearance of the signs and symptoms of stage IV RCC, a full 9 years following diagnosis, with a gentle integrative program, which is essentially free of side effects. As of November 2017 the patient feels well and is working at his full-time job.Keywords
This publication has 34 references indexed in Scilit:
- A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescenceNature, 2013
- Immunity, Inflammation, and CancerCell, 2010
- ATP-Citrate Lyase Links Cellular Metabolism to Histone AcetylationScience, 2009
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Pyruvate Dehydrogenase Complex Activity Controls Metabolic and Malignant Phenotype in Cancer CellsJournal of Biological Chemistry, 2008
- Dietary histone deacetylase inhibitors: From cells to mice to manSeminars in Cancer Biology, 2007
- α‐Lipoic acid induces p27Kip‐dependent cell cycle arrest in non‐transformed cell lines and apoptosis in tumor cell linesJournal of Cellular Physiology, 2003
- Thioctic Acid in Treatment of Hepatotoxic Mushroom (Phalloides) PoisoningNew England Journal of Medicine, 1979
- Probable Atypical Measles Pneumonia without RashNew England Journal of Medicine, 1979
- On the Origin of Cancer CellsScience, 1956